Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
KO-2806 by Kura Oncology for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...